You just read:

New Published Data and Recent Positive Private Payor Coverage Decisions Underscore Value and Utility of the Oncotype DX Genomic Prostate Score® (GPS™) Test

News provided by

Genomic Health, Inc.

Sep 28, 2018, 08:00 ET